Predicting the Development of Myocardial Depression in Acute Neurological Patients

Completed

Conditions studied: Myocardial Depression, Takotsubo Syndrome, Subarachnoid Hemorrhage, Acute Ischemic Stroke

In brief

The purpose of this study is to assess the levels of serum catecholamines associated with myocardial depression (MD) in patients with acute neurological injury.

Key facts

Study ID

NCT03801694

Run by

Ohio State University

People needed

4

Starts

2018-12-03

Expected to finish

2024-04-14

Last updated by the study team

2024-04-16

Who can join

Age: 50 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• female patients >50 years admitted to the neuro ICU with diagnosis of either acute ischemic stroke or subarachnoid hemorrhage
• Only patients predicted to be on norepinephrine infusion for at least 48 hrs will be selected.

You may not qualify if…

• patients with known history of heart failure will be excluded
• Patients with history of coronary artery disease, smoking, poorly controlled diabetes with HbA1c >8 and uncontrolled hypertension will be excluded.
• Patients with poor ECHO windows will be excluded

Where it is running

• The Ohio Sate University — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.